Analyze Diet
Frontiers in veterinary science2023; 10; 1045030; doi: 10.3389/fvets.2023.1045030

Expression of cannabinoid (CB1 and CB2) and cannabinoid-related receptors (TRPV1, GPR55, and PPARα) in the synovial membrane of the horse metacarpophalangeal joint.

Abstract: The metacarpophalangeal joint undergoes enormous loading during locomotion and can therefore often become inflamed, potentially resulting in osteoarthritis (OA). There are studies indicating that the endocannabinoid system (ECS) modulates synovium homeostasis, and could be a promising target for OA therapy. Some cannabinoid receptors, which modulate proliferative and secretory responses in joint inflammation, have been functionally identified in human and animal synovial cells. Unassigned: To characterize the cellular distribution of the cannabinoid receptors 1 (CB1R) and 2 (CB2R), and the cannabinoid-related receptors transient receptor potential vanilloid type 1 (TRPV1), G protein-related receptor 55 (GPR55) and peroxisome proliferator-activated receptor alpha (PPARα) in the synovial membrane of the metacarpophalangeal joint of the horse. Unassigned: The dorsal synovial membranes of 14 equine metacarpophalangeal joints were collected post-mortem from an abattoir. Unassigned: The dorsal synovial membranes of 14 equine metacarpophalangeal joints were collected post-mortem from an abattoir. The expression of the CB1R, CB2R, TRPV1, GPR55, and PPARα in synovial tissues was studied using qualitative and quantitative immunofluorescence, and quantitative real-time reverse transcriptase PCR (qRT-PCR). Macrophage-like (MLS) and fibroblast-like (FLS) synoviocytes were identified by means of antibodies directed against IBA1 and vimentin, respectively. Unassigned: Both the mRNA and protein expression of the CB2R, TRPV1, GPR55, and PPARα were found in the synoviocytes and blood vessels of the metacarpophalangeal joints. The synoviocytes expressed the mRNA and protein of the CB1R in some of the horses investigated, but not in all. Unassigned: Given the expression of the CB1R, CB2R, TRPV1, GPR55, and PPARα in the synovial elements of the metacarpophalangeal joint, these findings encouraged the development of new studies supporting the use of molecules acting on these receptors to reduce the inflammation during joint inflammation in the horse.
Publication Date: 2023-03-03 PubMed ID: 36937015PubMed Central: PMC10020506DOI: 10.3389/fvets.2023.1045030Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article focuses on investigating the cellular distribution of certain cannabinoid and cannabinoid-related receptors in the synovial membrane (the protective layer that lines joint cavities) of the horse metacarpophalangeal joint. Their presence suggests a potential for therapies targeting these receptors to reduce joint inflammation in horses.

Understanding the Research

  • The metacarpophalangeal joint in horses carries a lot of weight, which often leads to inflammation and can result in osteoarthritis (OA). The defining characteristic of OA is the breakdown of joint cartilage, leading to painful bone-to-bone contact.
  • Prior studies suggest that the endocannabinoid system (ECS), which includes receptors and enzymes that produce and degrade cannabinoids, could potentially be a therapeutic target for OA. Cannabinoid receptors can modulate proliferative and secretory responses during joint inflammation.

Objective of the Study

  • The intent of this study was to determine the expression of certain cannabinoid receptors – 1 (CB1R) and 2 (CB2R) – and cannabinoid-related receptors – transient receptor potential vanilloid type 1 (TRPV1), G protein-related receptor 55 (GPR55) and peroxisome proliferator-activated receptor-alpha (PPARα) – in the synovial membrane of a horse’s metacarpophalangeal joint.

Methodology of the Study

  • The research involves studying tissues post-mortem from the equine metacarpophalangeal joints using both qualitative and quantitative immunofluorescence, and quantity real-time reverse transcriptase PCR (qRT-PCR) – techniques used to measure the presence of certain proteins or genes.
  • Macrophage-like (cells that play a crucial role in innate immunity) and fibroblast-like (cells that produce the structural framework for tissues) synoviocytes were identified using specific antibodies.

Findings of the Study

  • The findings reveal that both the messenger RNA (mRNA) and proteins for CB2R, TRPV1, GPR55, and PPARα were found in synoviocytes and blood vessels in the metacarpophalangeal joints. These receptors’ role in the ECS is possibly linked to the modulation of pain and inflammation.
  • The expression of CB1R was detected in the mRNA and protein of the synoviocytes of only some of the examined horses, indicating a possible variance in expression among individual animals.

Impact of the Study

  • The study’s results suggest the potential for developing therapies targeting these receptors to reduce inflammation in the joints of horses. With the expressions of CB1R, CB2R, TRPV1, GPR55, and PPARα identified in the joint’s synovial elements, this paves the way for future research into the use of molecules that act on these receptors.

Cite This Article

APA
Zamith Cunha R, Zannoni A, Salamanca G, De Silva M, Rinnovati R, Gramenzi A, Forni M, Chiocchetti R. (2023). Expression of cannabinoid (CB1 and CB2) and cannabinoid-related receptors (TRPV1, GPR55, and PPARα) in the synovial membrane of the horse metacarpophalangeal joint. Front Vet Sci, 10, 1045030. https://doi.org/10.3389/fvets.2023.1045030

Publication

ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 10
Pages: 1045030
PII: 1045030

Researcher Affiliations

Zamith Cunha, Rodrigo
  • Department of Veterinary Medical Sciences (UNI EN ISO 9001:2008), University of Bologna, Bologna, Italy.
Zannoni, Augusta
  • Department of Veterinary Medical Sciences (UNI EN ISO 9001:2008), University of Bologna, Bologna, Italy.
Salamanca, Giulia
  • Department of Veterinary Medical Sciences (UNI EN ISO 9001:2008), University of Bologna, Bologna, Italy.
De Silva, Margherita
  • Department of Veterinary Medical Sciences (UNI EN ISO 9001:2008), University of Bologna, Bologna, Italy.
Rinnovati, Riccardo
  • Department of Veterinary Medical Sciences (UNI EN ISO 9001:2008), University of Bologna, Bologna, Italy.
Gramenzi, Alessandro
  • Faculty of Veterinary Medicine, Università degli Studi di Teramo, Teramo, Italy.
Forni, Monica
  • Department of Veterinary Medical Sciences (UNI EN ISO 9001:2008), University of Bologna, Bologna, Italy.
Chiocchetti, Roberto
  • Department of Veterinary Medical Sciences (UNI EN ISO 9001:2008), University of Bologna, Bologna, Italy.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

This article includes 136 references
  1. Lapjit C, Charoenchanikran P, Petchkaew P, Sukpipattanamongkol S, Yodsheewan R, Theerapan W, Chanda M. Diagnostic Imaging and Cytological Analysis Aid the Clinical Investigation of Long Digital Extensor Tendon Subtendinous Bursitis in a Horse.. J Equine Vet Sci 2021 Jun;101:103449.
    doi: 10.1016/j.jevs.2021.103449pubmed: 33993936google scholar: lookup
  2. Kawcak CE, McIlwraith CW, Norrdin RW, Park RD, Steyn PS. Clinical effects of exercise on subchondral bone of carpal and metacarpophalangeal joints in horses.. Am J Vet Res 2000 Oct;61(10):1252-8.
    doi: 10.2460/ajvr.2000.61.1252pubmed: 11039557google scholar: lookup
  3. Neundorf RH, Lowerison MB, Cruz AM, Thomason JJ, McEwen BJ, Hurtig MB. Determination of the prevalence and severity of metacarpophalangeal joint osteoarthritis in Thoroughbred racehorses via quantitative macroscopic evaluation.. Am J Vet Res 2010 Nov;71(11):1284-93.
    doi: 10.2460/ajvr.71.11.1284pubmed: 21034319google scholar: lookup
  4. Braucke AFGV, Frederiksen NL, Berg LC, Aarsvold S, Müller FC, Boesen MP, Lindegaard C. Identification and Quantification of Transient Receptor Potential Vanilloid 1 (TRPV1) in Equine Articular Tissue.. Animals (Basel) 2020 Mar 18;10(3).
    doi: 10.3390/ani10030506pmc: PMC7143842pubmed: 32197454google scholar: lookup
  5. Contino EK. Management and Rehabilitation of Joint Disease in Sport Horses.. Vet Clin North Am Equine Pract 2018 Aug;34(2):345-358.
    doi: 10.1016/j.cveq.2018.04.007pubmed: 29793734google scholar: lookup
  6. Spadari A, Rinnovati R, Babbini S, Romagnoli N. Clinical evaluation of intra-articular administration of stanozolol to manage lameness associated with acute and chronic osteoarthritis in horses. J Equine Vet Sci (2015) 35:105–10.
  7. Pujol R, Girard CA, Richard H, Hassanpour I, Binette MP, Beauchamp G, McDougall JJ, Laverty S. Synovial nerve fiber density decreases with naturally-occurring osteoarthritis in horses.. Osteoarthritis Cartilage 2018 Oct;26(10):1379-1388.
    doi: 10.1016/j.joca.2018.06.006pubmed: 29958917google scholar: lookup
  8. Goodrich LR, Nixon AJ. Medical treatment of osteoarthritis in the horse - a review.. Vet J 2006 Jan;171(1):51-69.
    doi: 10.1016/j.tvjl.2004.07.008pubmed: 16427582google scholar: lookup
  9. Bondeson J, Wainwright SD, Lauder S, Amos N, Hughes CE. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis.. Arthritis Res Ther 2006;8(6):R187.
    doi: 10.1186/ar2099pmc: PMC1794533pubmed: 17177994google scholar: lookup
  10. Chang SK, Gu Z, Brenner MB. Fibroblast-like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin-11.. Immunol Rev 2010 Jan;233(1):256-66.
  11. Iwanaga T, Shikichi M, Kitamura H, Yanase H, Nozawa-Inoue K. Morphology and functional roles of synoviocytes in the joint.. Arch Histol Cytol 2000 Mar;63(1):17-31.
    doi: 10.1679/aohc.63.17pubmed: 10770586google scholar: lookup
  12. Lowin T, Pongratz G, Straub RH. The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets.. J Inflamm (Lond) 2016;13:15.
    doi: 10.1186/s12950-016-0114-7pmc: PMC4858820pubmed: 27158245google scholar: lookup
  13. Thomsen LN, Thomsen PD, Downing A, Talbot R, Berg LC. FOXO1, PXK, PYCARD and SAMD9L are differentially expressed by fibroblast-like cells in equine synovial membrane compared to joint capsule.. BMC Vet Res 2017 Apr 14;13(1):106.
    doi: 10.1186/s12917-017-1003-xpmc: PMC5391632pubmed: 28410619google scholar: lookup
  14. Graabaek PM. Ultrastructural evidence for two distinct types of synoviocytes in rat synovial membrane.. J Ultrastruct Res 1982 Mar;78(3):321-39.
    doi: 10.1016/S0022-5320(82)80006-3pubmed: 7086939google scholar: lookup
  15. Nygaard G, Firestein GS. Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes.. Nat Rev Rheumatol 2020 Jun;16(6):316-333.
    doi: 10.1038/s41584-020-0413-5pmc: PMC7987137pubmed: 32393826google scholar: lookup
  16. Kitamura HP, Yanase H, Kitamura H, Iwanaga T. Unique localization of protein gene product 9.5 in type B synoviocytes in the joints of the horse.. J Histochem Cytochem 1999 Mar;47(3):343-52.
    doi: 10.1177/002215549904700308pubmed: 10026236google scholar: lookup
  17. Shikichi M, Kitamura HP, Yanase H, Konno A, Takahashi-Iwanaga H, Iwanaga T. Three-dimensional ultrastructure of synoviocytes in the horse joint as revealed by the scanning electron microscope.. Arch Histol Cytol 1999 Aug;62(3):219-29.
    doi: 10.1679/aohc.62.219pubmed: 10495876google scholar: lookup
  18. Levick JR, McDonald JN. Fluid movement across synovium in healthy joints: role of synovial fluid macromolecules.. Ann Rheum Dis 1995 May;54(5):417-23.
    doi: 10.1136/ard.54.5.417pmc: PMC1005608pubmed: 7794053google scholar: lookup
  19. Karpus ON, Kiener HP, Niederreiter B, Yilmaz-Elis AS, van der Kaa J, Ramaglia V, Arens R, Smolen JS, Botto M, Tak PP, Verbeek JS, Hamann J. CD55 deposited on synovial collagen fibers protects from immune complex-mediated arthritis.. Arthritis Res Ther 2015 Jan 17;17(1):6.
    doi: 10.1186/s13075-015-0518-4pmc: PMC4325944pubmed: 25596646google scholar: lookup
  20. Haubruck P, Pinto MM, Moradi B, Little CB, Gentek R. Monocytes, Macrophages, and Their Potential Niches in Synovial Joints - Therapeutic Targets in Post-Traumatic Osteoarthritis?. Front Immunol 2021;12:763702.
    doi: 10.3389/fimmu.2021.763702pmc: PMC8600114pubmed: 34804052google scholar: lookup
  21. Müller-Ladner U, Ospelt C, Gay S, Distler O, Pap T. Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts.. Arthritis Res Ther 2007;9(6):223.
    doi: 10.1186/ar2337pmc: PMC2246247pubmed: 18177509google scholar: lookup
  22. Kiener HP, Watts GF, Cui Y, Wright J, Thornhill TS, Sköld M, Behar SM, Niederreiter B, Lu J, Cernadas M, Coyle AJ, Sims GP, Smolen J, Warman ML, Brenner MB, Lee DM. Synovial fibroblasts self-direct multicellular lining architecture and synthetic function in three-dimensional organ culture.. Arthritis Rheum 2010 Mar;62(3):742-52.
    doi: 10.1002/art.27285pubmed: 20131230google scholar: lookup
  23. Davies LC, Jenkins SJ, Allen JE, Taylor PR. Tissue-resident macrophages.. Nat Immunol 2013 Oct;14(10):986-95.
    doi: 10.1038/ni.2705pmc: PMC4045180pubmed: 24048120google scholar: lookup
  24. Culemann S, Grüneboom A, Nicolás-Ávila JÁ, Weidner D, Lämmle KF, Rothe T, Quintana JA, Kirchner P, Krljanac B, Eberhardt M, Ferrazzi F, Kretzschmar E, Schicht M, Fischer K, Gelse K, Faas M, Pfeifle R, Ackermann JA, Pachowsky M, Renner N, Simon D, Haseloff RF, Ekici AB, Bäuerle T, Blasig IE, Vera J, Voehringer D, Kleyer A, Paulsen F, Schett G, Hidalgo A, Krönke G. Locally renewing resident synovial macrophages provide a protective barrier for the joint.. Nature 2019 Aug;572(7771):670-675.
    doi: 10.1038/s41586-019-1471-1pmc: PMC6805223pubmed: 31391580google scholar: lookup
  25. Buckley CD. Macrophages form a protective cellular barrier in joints.. Nature 2019 Aug;572(7771):590-592.
    doi: 10.1038/d41586-019-02340-xpubmed: 31444488google scholar: lookup
  26. Menarim BC, Gillis KH, Oliver A, Mason C, Werre SR, Luo X, Byron CR, Kalbfleisch TS, MacLeod JN, Dahlgren LA. Inflamed synovial fluid induces a homeostatic response in bone marrow mononuclear cells in vitro: Implications for joint therapy.. FASEB J 2020 Mar;34(3):4430-4444.
    doi: 10.1096/fj.201902698Rpubmed: 32030831google scholar: lookup
  27. Malfait AM, Gallily R, Sumariwalla PF, Malik AS, Andreakos E, Mechoulam R, Feldmann M. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.. Proc Natl Acad Sci U S A 2000 Aug 15;97(17):9561-6.
    doi: 10.1073/pnas.160105897pmc: PMC16904pubmed: 10920191google scholar: lookup
  28. Richardson D, Pearson RG, Kurian N, Latif ML, Garle MJ, Barrett DA, Kendall DA, Scammell BE, Reeve AJ, Chapman V. Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis.. Arthritis Res Ther 2008;10(2):R43.
    doi: 10.1186/ar2401pmc: PMC2453762pubmed: 18416822google scholar: lookup
  29. Gui H, Tong Q, Qu W, Mao CM, Dai SM. The endocannabinoid system and its therapeutic implications in rheumatoid arthritis.. Int Immunopharmacol 2015 May;26(1):86-91.
    doi: 10.1016/j.intimp.2015.03.006pubmed: 25791728google scholar: lookup
  30. Gui H, Liu X, Liu LR, Su DF, Dai SM. Activation of cannabinoid receptor 2 attenuates synovitis and joint distruction in collagen-induced arthritis.. Immunobiology 2015 Jun;220(6):817-22.
    doi: 10.1016/j.imbio.2014.12.012pubmed: 25601571google scholar: lookup
  31. Lowin T, Apitz M, Anders S, Straub RH. Anti-inflammatory effects of N-acylethanolamines in rheumatoid arthritis synovial cells are mediated by TRPV1 and TRPA1 in a COX-2 dependent manner.. Arthritis Res Ther 2015 Nov 14;17:321.
    doi: 10.1186/s13075-015-0845-5pmc: PMC4644337pubmed: 26567045google scholar: lookup
  32. Malek N, Starowicz K. Joint problems arising from lack of repair mechanisms: can cannabinoids help?. Br J Pharmacol 2019 May;176(10):1412-1420.
    doi: 10.1111/bph.14204pmc: PMC6487548pubmed: 29574720google scholar: lookup
  33. Kaur I, Behl T, Bungau S, Zengin G, Kumar A, El-Esawi MA, Khullar G, Venkatachalam T, Arora S. The endocannabinoid signaling pathway as an emerging target in pharmacotherapy, earmarking mitigation of destructive events in rheumatoid arthritis.. Life Sci 2020 Sep 15;257:118109.
    doi: 10.1016/j.lfs.2020.118109pubmed: 32698072google scholar: lookup
  34. Clayton P, Hill M, Bogoda N, Subah S, Venkatesh R. Palmitoylethanolamide: A Natural Compound for Health Management.. Int J Mol Sci 2021 May 18;22(10).
    doi: 10.3390/ijms22105305pmc: PMC8157570pubmed: 34069940google scholar: lookup
  35. Ligresti A, De Petrocellis L, Di Marzo V. From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology.. Physiol Rev 2016 Oct;96(4):1593-659.
    doi: 10.1152/physrev.00002.2016pubmed: 27630175google scholar: lookup
  36. Maroon J, Bost J. Review of the neurological benefits of phytocannabinoids.. Surg Neurol Int 2018;9:91.
    doi: 10.4103/sni.sni_45_18pmc: PMC5938896pubmed: 29770251google scholar: lookup
  37. Kreitzer FR, Stella N. The therapeutic potential of novel cannabinoid receptors.. Pharmacol Ther 2009 May;122(2):83-96.
  38. Morales P, Hurst DP, Reggio PH. Molecular Targets of the Phytocannabinoids: A Complex Picture.. Prog Chem Org Nat Prod 2017;103:103-131.
    pmc: PMC5345356pubmed: 28120232doi: 10.1007/978-3-319-45541-9_4google scholar: lookup
  39. Mlost J, Bryk M, Starowicz K. Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action.. Int J Mol Sci 2020 Nov 23;21(22).
    doi: 10.3390/ijms21228870pmc: PMC7700528pubmed: 33238607google scholar: lookup
  40. Selvi E, Lorenzini S, Garcia-Gonzalez E, Maggio R, Lazzerini PE, Capecchi PL, Balistreri E, Spreafico A, Niccolini S, Pompella G, Natale MR, Guideri F, Laghi Pasini F, Galeazzi M, Marcolongo R. Inhibitory effect of synthetic cannabinoids on cytokine production in rheumatoid fibroblast-like synoviocytes.. Clin Exp Rheumatol 2008 Jul-Aug;26(4):574-81.
    pubmed: 18799087
  41. Schuelert N, Zhang C, Mogg AJ, Broad LM, Hepburn DL, Nisenbaum ES, Johnson MP, McDougall JJ. Paradoxical effects of the cannabinoid CB2 receptor agonist GW405833 on rat osteoarthritic knee joint pain.. Osteoarthritis Cartilage 2010 Nov;18(11):1536-43.
    doi: 10.1016/j.joca.2010.09.005pubmed: 20863899google scholar: lookup
  42. Fukuda S, Kohsaka H, Takayasu A, Yokoyama W, Miyabe C, Miyabe Y, Harigai M, Miyasaka N, Nanki T. Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis.. BMC Musculoskelet Disord 2014 Aug 12;15:275.
    doi: 10.1186/1471-2474-15-275pmc: PMC4243420pubmed: 25115332google scholar: lookup
  43. Gui H, Liu X, Wang ZW, He DY, Su DF, Dai SM. Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis.. Rheumatology (Oxford) 2014 May;53(5):802-9.
    doi: 10.1093/rheumatology/ket447pubmed: 24440992google scholar: lookup
  44. Miagkoff L, Girard CA, St-Jean G, Richard H, Beauchamp G, Laverty S. Cannabinoid receptors are expressed in equine synovium and upregulated with synovitis.. Equine Vet J 2023 Jul;55(4):681-695.
    doi: 10.1111/evj.13860pubmed: 35836386google scholar: lookup
  45. Rzeczycki P, Rasner C, Lammlin L, Junginger L, Goldman S, Bergman R, Redding S, Knights AJ, Elliott M, Maerz T. Cannabinoid receptor type 2 is upregulated in synovium following joint injury and mediates anti-inflammatory effects in synovial fibroblasts and macrophages.. Osteoarthritis Cartilage 2021 Dec;29(12):1720-1731.
    doi: 10.1016/j.joca.2021.09.003pmc: PMC8883578pubmed: 34537380google scholar: lookup
  46. Kochukov MY, McNearney TA, Fu Y, Westlund KN. Thermosensitive TRP ion channels mediate cytosolic calcium response in human synoviocytes.. Am J Physiol Cell Physiol 2006 Sep;291(3):C424-32.
    doi: 10.1152/ajpcell.00553.2005pubmed: 16597917google scholar: lookup
  47. Whyte LS, Ryberg E, Sims NA, Ridge SA, Mackie K, Greasley PJ, Ross RA, Rogers MJ. The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo.. Proc Natl Acad Sci U S A 2009 Sep 22;106(38):16511-6.
    doi: 10.1073/pnas.0902743106pmc: PMC2737440pubmed: 19805329google scholar: lookup
  48. Andersson J, Sophocleous A, Zhou Y, Rischitor G, Ralston S, Salter D. Expression of cannabinoid receptors by human articular chondrocytes. Bone (2011) 48:S141.
  49. van Eekeren IC, Clockaerts S, Bastiaansen-Jenniskens YM, Lubberts E, Verhaar JA, van Osch GJ, Bierma-Zeinstra SM. Fibrates as therapy for osteoarthritis and rheumatoid arthritis? A systematic review.. Ther Adv Musculoskelet Dis 2013 Feb;5(1):33-44.
    doi: 10.1177/1759720X12468659pmc: PMC3582306pubmed: 23515070google scholar: lookup
  50. Huang D, Zhao Q, Liu H, Guo Y, Xu H. PPAR-α Agonist WY-14643 Inhibits LPS-Induced Inflammation in Synovial Fibroblasts via NF-kB Pathway.. J Mol Neurosci 2016 Aug;59(4):544-53.
    doi: 10.1007/s12031-016-0775-ypubmed: 27339772google scholar: lookup
  51. Zannoni A, Bombardi C, Dondi F, Morini M, Forni M, Chiocchetti R, Spadari A, Romagnoli N. Proteinase-activated receptor 2 expression in the intestinal tract of the horse.. Res Vet Sci 2014 Jun;96(3):464-71.
    doi: 10.1016/j.rvsc.2014.03.006pubmed: 24656343google scholar: lookup
  52. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.. Genome Biol 2002 Jun 18;3(7):RESEARCH0034.
  53. Galiazzo G, De Silva M, Giancola F, Rinnovati R, Peli A, Chiocchetti R. Cellular distribution of cannabinoid-related receptors TRPV1, PPAR-gamma, GPR55 and GPR3 in the equine cervical dorsal root ganglia.. Equine Vet J 2021 Aug 21;54(4):788-98.
    doi: 10.1111/evj.13499pmc: PMC9293124pubmed: 34418142google scholar: lookup
  54. Chiocchetti R, Rinnovati R, Tagliavia C, Stanzani A, Galiazzo G, Giancola F, Silva M, Capodanno Y, Spadari A. Localisation of cannabinoid and cannabinoid-related receptors in the equine dorsal root ganglia.. Equine Vet J 2021 May;53(3):549-557.
    doi: 10.1111/evj.13305pubmed: 32524649google scholar: lookup
  55. Kupczyk P, Rykala M, Serek P, Pawlak A, Slowikowski B, Holysz M, Chodaczek G, Madej JP, Ziolkowski P, Niedzwiedz A. The cannabinoid receptors system in horses: Tissue distribution and cellular identification in skin.. J Vet Intern Med 2022 Jul;36(4):1508-1524.
    doi: 10.1111/jvim.16467pmc: PMC9308437pubmed: 35801813google scholar: lookup
  56. Wang S, Kobayashi K, Kogure Y, Yamanaka H, Yamamoto S, Yagi H, Noguchi K, Dai Y. Negative Regulation of TRPA1 by AMPK in Primary Sensory Neurons as a Potential Mechanism of Painful Diabetic Neuropathy.. Diabetes 2018 Jan;67(1):98-109.
    doi: 10.2337/db17-0503pubmed: 29025860google scholar: lookup
  57. Chiocchetti R, Galiazzo G, Tagliavia C, Stanzani A, Giancola F, Menchetti M, Militerno G, Bernardini C, Forni M, Mandrioli L. Cellular Distribution of Canonical and Putative Cannabinoid Receptors in Canine Cervical Dorsal Root Ganglia.. Front Vet Sci 2019;6:313.
    doi: 10.3389/fvets.2019.00313pmc: PMC6761858pubmed: 31608295google scholar: lookup
  58. Galiazzo G, Giancola F, Stanzani A, Fracassi F, Bernardini C, Forni M, Pietra M, Chiocchetti R. Localization of cannabinoid receptors CB1, CB2, GPR55, and PPARα in the canine gastrointestinal tract.. Histochem Cell Biol 2018 Aug;150(2):187-205.
    doi: 10.1007/s00418-018-1684-7pubmed: 29882158google scholar: lookup
  59. Jørgensen E, Pirone A, Jacobsen S, Miragliotta V. Epithelial-to-mesenchymal transition and keratinocyte differentiation in equine experimental body and limb wounds healing by second intention.. Vet Dermatol 2019 Oct;30(5):417-e126.
    doi: 10.1111/vde.12774pubmed: 31328349google scholar: lookup
  60. Cerrato S, Ramió-Lluch L, Brazís P, Rabanal RM, Fondevila D, Puigdemont A. Development and characterization of an equine skin-equivalent model.. Vet Dermatol 2014 Oct;25(5):475-e77.
    doi: 10.1111/vde.12134pubmed: 25041278google scholar: lookup
  61. Smith MD. The normal synovium.. Open Rheumatol J 2011;5:100-6.
    doi: 10.2174/1874312901105010100pmc: PMC3263506pubmed: 22279508google scholar: lookup
  62. Kupczyk P, Simiczyjew A, Marczuk J, Dratkiewicz E, Beberok A, Rok J, Pieniazek M, Biecek P, Nevozhay D, Slowikowski B, Chodaczek G, Wrzesniok D, Nowak D, Donizy P. PARP1 as a Marker of an Aggressive Clinical Phenotype in Cutaneous Melanoma-A Clinical and an In Vitro Study.. Cells 2021 Jan 31;10(2).
    doi: 10.3390/cells10020286pmc: PMC7911865pubmed: 33572647google scholar: lookup
  63. Kleine SA, Budsberg SC. Synovial membrane receptors as therapeutic targets: A review of receptor localization, structure, and function.. J Orthop Res 2017 Aug;35(8):1589-1605.
    doi: 10.1002/jor.23568pubmed: 28374922google scholar: lookup
  64. O'Brien M, McDougall JJ. Cannabis and joints: scientific evidence for the alleviation of osteoarthritis pain by cannabinoids.. Curr Opin Pharmacol 2018 Jun;40:104-109.
    doi: 10.1016/j.coph.2018.03.012pubmed: 29635215google scholar: lookup
  65. Yocom AF, O'Fallon ES, Gustafson DL, Contino EK. Pharmacokinetics, Safety, and Synovial Fluid Concentrations of Single- and Multiple-Dose Oral Administration of 1 and 3 mg/kg Cannabidiol in Horses.. J Equine Vet Sci 2022 Jun;113:103933.
    doi: 10.1016/j.jevs.2022.103933pubmed: 35307550google scholar: lookup
  66. Valencia X, Higgins JM, Kiener HP, Lee DM, Podrebarac TA, Dascher CC, Watts GF, Mizoguchi E, Simmons B, Patel DD, Bhan AK, Brenner MB. Cadherin-11 provides specific cellular adhesion between fibroblast-like synoviocytes.. J Exp Med 2004 Dec 20;200(12):1673-9.
    doi: 10.1084/jem.20041545pmc: PMC2211995pubmed: 15611293google scholar: lookup
  67. Müller-Ladner U, Gay RE, Gay S. Activation of synoviocytes.. Curr Opin Rheumatol 2000 May;12(3):186-94.
  68. Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis.. Immunol Rev 2010 Jan;233(1):233-55.
  69. Bottini N, Firestein GS. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors.. Nat Rev Rheumatol 2013 Jan;9(1):24-33.
    doi: 10.1038/nrrheum.2012.190pmc: PMC3970924pubmed: 23147896google scholar: lookup
  70. Briston L, Dudhia J, Lees P. Age-related differences in prostaglandin E2 synthesis by equine cartilage explants and synoviocytes.. J Vet Pharmacol Ther 2010 Jun 1;33(3):268-76.
  71. Benito MJ, Veale DJ, FitzGerald O, van den Berg WB, Bresnihan B. Synovial tissue inflammation in early and late osteoarthritis.. Ann Rheum Dis 2005 Sep;64(9):1263-7.
    doi: 10.1136/ard.2004.025270pmc: PMC1755629pubmed: 15731292google scholar: lookup
  72. Ross TN, Kisiday JD, Hess T, McIlwraith CW. Evaluation of the inflammatory response in experimentally induced synovitis in the horse: a comparison of recombinant equine interleukin 1 beta and lipopolysaccharide.. Osteoarthritis Cartilage 2012 Dec;20(12):1583-90.
    doi: 10.1016/j.joca.2012.08.008pubmed: 22917743google scholar: lookup
  73. Andreassen SM, Berg LC, Nielsen SS, Kristensen AT, Jacobsen S. mRNA expression of genes involved in inflammation and haemostasis in equine fibroblast-like synoviocytes following exposure to lipopolysaccharide, fibrinogen and thrombin.. BMC Vet Res 2015 Jun 27;11:141.
    doi: 10.1186/s12917-015-0448-zpmc: PMC4483216pubmed: 26116380google scholar: lookup
  74. Culemann S, Grüneboom A, Krönke G. Origin and function of synovial macrophage subsets during inflammatory joint disease.. Adv Immunol 2019;143:75-98.
    doi: 10.1016/bs.ai.2019.08.006pubmed: 31607368google scholar: lookup
  75. Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, Gordon S, Hamilton JA, Ivashkiv LB, Lawrence T, Locati M, Mantovani A, Martinez FO, Mege JL, Mosser DM, Natoli G, Saeij JP, Schultze JL, Shirey KA, Sica A, Suttles J, Udalova I, van Ginderachter JA, Vogel SN, Wynn TA. Macrophage activation and polarization: nomenclature and experimental guidelines.. Immunity 2014 Jul 17;41(1):14-20.
  76. Udalova IA, Mantovani A, Feldmann M. Macrophage heterogeneity in the context of rheumatoid arthritis.. Nat Rev Rheumatol 2016 Aug;12(8):472-85.
    doi: 10.1038/nrrheum.2016.91pubmed: 27383913google scholar: lookup
  77. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets.. Nat Rev Immunol 2011 Oct 14;11(11):723-37.
    doi: 10.1038/nri3073pmc: PMC3422549pubmed: 21997792google scholar: lookup
  78. Yocum DE, Lafyatis R, Remmers EF, Schumacher HR, Wilder RL. Hyperplastic synoviocytes from rats with streptococcal cell wall-induced arthritis exhibit a transformed phenotype that is thymic-dependent and retinoid inhibitable.. Am J Pathol 1988 Jul;132(1):38-48.
    pmc: PMC1880616pubmed: 3260752
  79. Xue C, Takahashi M, Hasunuma T, Aono H, Yamamoto K, Yoshino S, Sumida T, Nishioka K. Characterisation of fibroblast-like cells in pannus lesions of patients with rheumatoid arthritis sharing properties of fibroblasts and chondrocytes.. Ann Rheum Dis 1997 Apr;56(4):262-7.
    doi: 10.1136/ard.56.4.262pmc: PMC1752353pubmed: 9166000google scholar: lookup
  80. Steinert PM, Roop DR. Molecular and cellular biology of intermediate filaments.. Annu Rev Biochem 1988;57:593-625.
  81. Cain H, Kraus B. Cytoskeleton in cells of the mononuclear phagocyte system. Immunofluorescence microscopic and electron microscopic studies.. Virchows Arch B Cell Pathol Incl Mol Pathol 1981;36(2-3):159-76.
    doi: 10.1007/BF02912064pubmed: 6116332google scholar: lookup
  82. Galiazzo G, Tagliavia C, Giancola F, Rinnovati R, Sadeghinezhad J, Bombardi C, Grandis A, Pietra M, Chiocchetti R. Localisation of Cannabinoid and Cannabinoid-Related Receptors in the Horse Ileum.. J Equine Vet Sci 2021 Sep;104:103688.
    doi: 10.1016/j.jevs.2021.103688pubmed: 34416995google scholar: lookup
  83. Croxford JL, Yamamura T. Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?. J Neuroimmunol 2005 Sep;166(1-2):3-18.
  84. Fechtner S, Singh AK, Ahmed S. Role of cannabinoid receptor 2 in mediating interleukin-1β-induced inflammation in rheumatoid arthritis synovial fibroblasts.. Clin Exp Rheumatol 2019 Nov-Dec;37(6):1026-1035.
    pubmed: 30943136
  85. Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, Raumann BE, Basbaum AI, Julius D. The cloned capsaicin receptor integrates multiple pain-producing stimuli.. Neuron 1998 Sep;21(3):531-43.
    doi: 10.1016/S0896-6273(00)80564-4pubmed: 9768840google scholar: lookup
  86. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway.. Nature 1997 Oct 23;389(6653):816-24.
    doi: 10.1038/39807pubmed: 9349813google scholar: lookup
  87. Kelly S. TRPV1 antagonists in the treatment of osteoarthritis pain. Int J Clin Rheumatol (2015) 10:161–75.
    doi: 10.2217/ijr.15.14google scholar: lookup
  88. Malfait AM, Butler DM, Presky DH, Maini RN, Brennan FM, Feldmann M. Blockade of IL-12 during the induction of collagen-induced arthritis (CIA) markedly attenuates the severity of the arthritis.. Clin Exp Immunol 1998 Feb;111(2):377-83.
  89. Kelly S, Chapman RJ, Woodhams S, Sagar DR, Turner J, Burston JJ, Bullock C, Paton K, Huang J, Wong A, McWilliams DF, Okine BN, Barrett DA, Hathway GJ, Walsh DA, Chapman V. Increased function of pronociceptive TRPV1 at the level of the joint in a rat model of osteoarthritis pain.. Ann Rheum Dis 2015 Jan;74(1):252-9.
  90. Lv Z, Xu X, Sun Z, Yang YX, Guo H, Li J, Sun K, Wu R, Xu J, Jiang Q, Ikegawa S, Shi D. TRPV1 alleviates osteoarthritis by inhibiting M1 macrophage polarization via Ca(2+)/CaMKII/Nrf2 signaling pathway.. Cell Death Dis 2021 May 18;12(6):504.
    doi: 10.1038/s41419-021-03792-8pmc: PMC8131608pubmed: 34006826google scholar: lookup
  91. Engler A, Aeschlimann A, Simmen BR, Michel BA, Gay RE, Gay S, Sprott H. Expression of transient receptor potential vanilloid 1 (TRPV1) in synovial fibroblasts from patients with osteoarthritis and rheumatoid arthritis.. Biochem Biophys Res Commun 2007 Aug 10;359(4):884-8.
    doi: 10.1016/j.bbrc.2007.05.178pubmed: 17560936google scholar: lookup
  92. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sørgård M, Di Marzo V, Julius D, Högestätt ED. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.. Nature 1999 Jul 29;400(6743):452-7.
    doi: 10.1038/22761pubmed: 10440374google scholar: lookup
  93. Patapoutian A, Peier AM, Story GM, Viswanath V. ThermoTRP channels and beyond: mechanisms of temperature sensation.. Nat Rev Neurosci 2003 Jul;4(7):529-39.
    doi: 10.1038/nrn1141pubmed: 12838328google scholar: lookup
  94. Anand U, Jones B, Korchev Y, Bloom SR, Pacchetti B, Anand P, Sodergren MH. CBD Effects on TRPV1 Signaling Pathways in Cultured DRG Neurons.. J Pain Res 2020;13:2269-2278.
    doi: 10.2147/JPR.S258433pmc: PMC7494392pubmed: 32982390google scholar: lookup
  95. Costa B, Trovato AE, Comelli F, Giagnoni G, Colleoni M. The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain.. Eur J Pharmacol 2007 Feb 5;556(1-3):75-83.
    doi: 10.1016/j.ejphar.2006.11.006pubmed: 17157290google scholar: lookup
  96. Lowin T, Tingting R, Zurmahr J, Classen T, Schneider M, Pongratz G. Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts.. Cell Death Dis 2020 Sep 1;11(8):714.
    doi: 10.1038/s41419-020-02892-1pmc: PMC7463000pubmed: 32873774google scholar: lookup
  97. Rajan TS, Giacoppo S, Iori R, De Nicola GR, Grassi G, Pollastro F, Bramanti P, Mazzon E. Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages.. Fitoterapia 2016 Jul;112:104-15.
    doi: 10.1016/j.fitote.2016.05.008pubmed: 27215129google scholar: lookup
  98. Lanuti M, Talamonti E, Maccarrone M, Chiurchiù V. Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages.. PLoS One 2015;10(5):e0126839.
  99. Schuelert N, McDougall JJ. The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55.. Neurosci Lett 2011 Aug 1;500(1):72-6.
    doi: 10.1016/j.neulet.2011.06.004pubmed: 21683763google scholar: lookup
  100. Sacerdote P, Martucci C, Vaccani A, Bariselli F, Panerai AE, Colombo A, Parolaro D, Massi P. The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro.. J Neuroimmunol 2005 Feb;159(1-2):97-105.
  101. Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors: new targets for the pharmacological modulation of macrophage gene expression and function.. Curr Opin Lipidol 2003 Oct;14(5):459-68.
  102. Shu H, Wong B, Zhou G, Li Y, Berger J, Woods JW, Wright SD, Cai TQ. Activation of PPARalpha or gamma reduces secretion of matrix metalloproteinase 9 but not interleukin 8 from human monocytic THP-1 cells.. Biochem Biophys Res Commun 2000 Jan 7;267(1):345-9.
    doi: 10.1006/bbrc.1999.1968pubmed: 10623622google scholar: lookup
  103. Pontis S, Ribeiro A, Sasso O, Piomelli D. Macrophage-derived lipid agonists of PPAR-α as intrinsic controllers of inflammation.. Crit Rev Biochem Mol Biol 2016;51(1):7-14.
    doi: 10.3109/10409238.2015.1092944pubmed: 26585314google scholar: lookup
  104. Grabacka M, Pierzchalska M, Płonka PM, Pierzchalski P. The Role of PPAR Alpha in the Modulation of Innate Immunity.. Int J Mol Sci 2021 Sep 29;22(19).
    doi: 10.3390/ijms221910545pmc: PMC8508635pubmed: 34638886google scholar: lookup
  105. Devchand PR, Keller H, Peters JM, Vazquez M, Gonzalez FJ, Wahli W. The PPARalpha-leukotriene B4 pathway to inflammation control.. Nature 1996 Nov 7;384(6604):39-43.
    doi: 10.1038/384039a0pubmed: 8900274google scholar: lookup
  106. Crisafulli C, Cuzzocrea S. The role of endogenous and exogenous ligands for the peroxisome proliferator-activated receptor alpha (PPAR-alpha) in the regulation of inflammation in macrophages.. Shock 2009 Jul;32(1):62-73.
    doi: 10.1097/SHK.0b013e31818bbad6pubmed: 19533851google scholar: lookup
  107. Okamoto H, Iwamoto T, Kotake S, Momohara S, Yamanaka H, Kamatani N. Inhibition of NF-kappaB signaling by fenofibrate, a peroxisome proliferator-activated receptor-alpha ligand, presents a therapeutic strategy for rheumatoid arthritis.. Clin Exp Rheumatol 2005 May-Jun;23(3):323-30.
    pubmed: 15971419
  108. Marini I, Bartolucci ML, Bortolotti F, Gatto MR, Bonetti GA. Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory pain.. J Orofac Pain 2012 Spring;26(2):99-104.
    pubmed: 22558609
  109. Jung JI, Lee HS, Jeon YE, Kim SM, Hong SH, Moon JM, Lim CY, Kim YH, Kim EJ. Anti-inflammatory activity of palmitoylethanolamide ameliorates osteoarthritis induced by monosodium iodoacetate in Sprague-Dawley rats.. Inflammopharmacology 2021 Oct;29(5):1475-1486.
    doi: 10.1007/s10787-021-00870-3pmc: PMC8514352pubmed: 34468900google scholar: lookup
  110. Ambrosino P, Soldovieri MV, De Maria M, Russo C, Taglialatela M. Functional and biochemical interaction between PPARα receptors and TRPV1 channels: Potential role in PPARα agonists-mediated analgesia.. Pharmacol Res 2014 Sep;87:113-22.
    doi: 10.1016/j.phrs.2014.06.015pubmed: 25014183google scholar: lookup
  111. Esteves CL, Sheldrake TA, Mesquita SP, Pesántez JJ, Menghini T, Dawson L, Péault B, Donadeu FX. Isolation and characterization of equine native MSC populations.. Stem Cell Res Ther 2017 Apr 18;8(1):80.
    doi: 10.1186/s13287-017-0525-2pmc: PMC5395828pubmed: 28420427google scholar: lookup
  112. Esteves CL, Sheldrake TA, Dawson L, Menghini T, Rink BE, Amilon K, Khan N, Péault B, Donadeu FX. Equine Mesenchymal Stromal Cells Retain a Pericyte-Like Phenotype.. Stem Cells Dev 2017 Jul 1;26(13):964-972.
    doi: 10.1089/scd.2017.0017pmc: PMC5510672pubmed: 28376684google scholar: lookup
  113. Earley S, Brayden JE. Transient receptor potential channels in the vasculature.. Physiol Rev 2015 Apr;95(2):645-90.
    doi: 10.1152/physrev.00026.2014pmc: PMC4551213pubmed: 25834234google scholar: lookup
  114. Mapp PI, Walsh DA. Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis.. Nat Rev Rheumatol 2012 May 29;8(7):390-8.
    doi: 10.1038/nrrheum.2012.80pubmed: 22641138google scholar: lookup
  115. Takeshita M, Nakamura J, Ohtori S, Inoue G, Orita S, Miyagi M, Ishikawa T, Takahashi K. Sensory innervation and inflammatory cytokines in hypertrophic synovia associated with pain transmission in osteoarthritis of the hip: a case-control study.. Rheumatology (Oxford) 2012 Oct;51(10):1790-5.
    doi: 10.1093/rheumatology/kes173pubmed: 22772321google scholar: lookup
  116. Henrotin Y, Pesesse L, Lambert C. Targeting the synovial angiogenesis as a novel treatment approach to osteoarthritis.. Ther Adv Musculoskelet Dis 2014 Feb;6(1):20-34.
    doi: 10.1177/1759720X13514669pmc: PMC3897168pubmed: 24489612google scholar: lookup
  117. Solinas M, Massi P, Cantelmo AR, Cattaneo MG, Cammarota R, Bartolini D, Cinquina V, Valenti M, Vicentini LM, Noonan DM, Albini A, Parolaro D. Cannabidiol inhibits angiogenesis by multiple mechanisms.. Br J Pharmacol 2012 Nov;167(6):1218-31.
  118. Balogh E, Biniecka M, Fearon U, Veale DJ, Szekanecz Z. Angiogenesis in Inflammatory Arthritis.. Isr Med Assoc J 2019 May;21(5):345-352.
    pubmed: 31140228
  119. Ashton JC, Friberg D, Darlington CL, Smith PF. Expression of the cannabinoid CB2 receptor in the rat cerebellum: an immunohistochemical study.. Neurosci Lett 2006 Mar 27;396(2):113-6.
    doi: 10.1016/j.neulet.2005.11.038pubmed: 16356641google scholar: lookup
  120. Bátkai S, Járai Z, Wagner JA, Goparaju SK, Varga K, Liu J, Wang L, Mirshahi F, Khanolkar AD, Makriyannis A, Urbaschek R, Garcia N Jr, Sanyal AJ, Kunos G. Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis.. Nat Med 2001 Jul;7(7):827-32.
    doi: 10.1038/89953pubmed: 11433348google scholar: lookup
  121. Sato J, Segami N, Yoshitake Y, Kaneyama K, Abe A, Yoshimura H, Fujimura K. Expression of capsaicin receptor TRPV-1 in synovial tissues of patients with symptomatic internal derangement of the temporomandibular joint and joint pain.. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005 Dec;100(6):674-81.
    doi: 10.1016/j.tripleo.2005.03.008pubmed: 16301147google scholar: lookup
  122. McDougall JJ, Yu V, Thomson J. In vivo effects of CB2 receptor-selective cannabinoids on the vasculature of normal and arthritic rat knee joints.. Br J Pharmacol 2008 Jan;153(2):358-66.
    doi: 10.1038/sj.bjp.0707565pmc: PMC2219539pubmed: 17982474google scholar: lookup
  123. Rajesh M, Mukhopadhyay P, Haskó G, Huffman JW, Mackie K, Pacher P. CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration.. Br J Pharmacol 2008 Jan;153(2):347-57.
    doi: 10.1038/sj.bjp.0707569pmc: PMC2219520pubmed: 17994109google scholar: lookup
  124. Yang D, Luo Z, Ma S, Wong WT, Ma L, Zhong J, He H, Zhao Z, Cao T, Yan Z, Liu D, Arendshorst WJ, Huang Y, Tepel M, Zhu Z. Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension.. Cell Metab 2010 Aug 4;12(2):130-41.
    doi: 10.1016/j.cmet.2010.05.015pmc: PMC3906919pubmed: 20674858google scholar: lookup
  125. Toschi A, Galiazzo G, Piva A, Tagliavia C, Mazzuoli-Weber G, Chiocchetti R, Grilli E. Cannabinoid and Cannabinoid-Related Receptors in the Myenteric Plexus of the Porcine Ileum.. Animals (Basel) 2021 Jan 21;11(2).
    doi: 10.3390/ani11020263pmc: PMC7912003pubmed: 33494452google scholar: lookup
  126. Tóth A, Czikora A, Pásztor ET, Dienes B, Bai P, Csernoch L, Rutkai I, Csató V, Mányiné IS, Pórszász R, Edes I, Papp Z, Boczán J. Vanilloid receptor-1 (TRPV1) expression and function in the vasculature of the rat.. J Histochem Cytochem 2014 Feb;62(2):129-44.
    doi: 10.1369/0022155413513589pmc: PMC3902097pubmed: 24217926google scholar: lookup
  127. Hofmann NA, Barth S, Waldeck-Weiermair M, Klec C, Strunk D, Malli R, Graier WF. TRPV1 mediates cellular uptake of anandamide and thus promotes endothelial cell proliferation and network-formation.. Biol Open 2014 Nov 13;3(12):1164-72.
    doi: 10.1242/bio.20149571pmc: PMC4265754pubmed: 25395667google scholar: lookup
  128. Blázquez C, Casanova ML, Planas A, Gómez Del Pulgar T, Villanueva C, Fernández-Aceñero MJ, Aragonés J, Huffman JW, Jorcano JL, Guzmán M. Inhibition of tumor angiogenesis by cannabinoids.. FASEB J 2003 Mar;17(3):529-31.
    doi: 10.1096/fj.02-0795fjepubmed: 12514108google scholar: lookup
  129. Stanley CP, Hind WH, Tufarelli C, O'Sullivan SE. Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation.. Cardiovasc Res 2015 Sep 1;107(4):568-78.
    doi: 10.1093/cvr/cvv179pmc: PMC4540144pubmed: 26092099google scholar: lookup
  130. Xu K, Shao Y, Saaoud F, Gillespie A, Drummer C 4th, Liu L, Lu Y, Sun Y, Xi H, Tükel Ç, Pratico D, Qin X, Sun J, Choi ET, Jiang X, Wang H, Yang X. Novel Knowledge-Based Transcriptomic Profiling of Lipid Lysophosphatidylinositol-Induced Endothelial Cell Activation.. Front Cardiovasc Med 2021;8:773473.
    doi: 10.3389/fcvm.2021.773473pmc: PMC8668339pubmed: 34912867google scholar: lookup
  131. Daly CJ, Ross RA, Whyte J, Henstridge CM, Irving AJ, McGrath JC. Fluorescent ligand binding reveals heterogeneous distribution of adrenoceptors and 'cannabinoid-like' receptors in small arteries.. Br J Pharmacol 2010 Feb;159(4):787-96.
  132. Zhang X, Maor Y, Wang JF, Kunos G, Groopman JE. Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator.. Br J Pharmacol 2010 Aug;160(7):1583-94.
  133. Wróbel A, Szopa A, Serefko A, Poleszak E. A Novel Alternative in the Treatment of Detrusor Overactivity? In Vivo Activity of O-1602, the Newly Synthesized Agonist of GPR55 and GPR18 Cannabinoid Receptors.. Molecules 2020 Mar 18;25(6).
    doi: 10.3390/molecules25061384pmc: PMC7144400pubmed: 32197469google scholar: lookup
  134. Karpińska O, Baranowska-Kuczko M, Malinowska B, Kloza M, Kusaczuk M, Gęgotek A, Golec P, Kasacka I, Kozłowska H. Mechanisms of l-alpha-lysophosphatidylinositol-induced relaxation in human pulmonary arteries.. Life Sci 2018 Jan 1;192:38-45.
    doi: 10.1016/j.lfs.2017.11.020pubmed: 29155298google scholar: lookup
  135. Hofmann NA, Yang J, Trauger SA, Nakayama H, Huang L, Strunk D, Moses MA, Klagsbrun M, Bischoff J, Graier WF. The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis.. Br J Pharmacol 2015 Aug;172(16):4107-18.
    doi: 10.1111/bph.13196pmc: PMC4543616pubmed: 25989290google scholar: lookup
  136. O'Sullivan SE. Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors.. Br J Pharmacol 2007 Nov;152(5):576-82.
    doi: 10.1038/sj.bjp.0707423pmc: PMC2190029pubmed: 17704824google scholar: lookup

Citations

This article has been cited 0 times.